Iterum Therapeutics plc
ITRMDelisted Jun 23, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001659323
Iterum Therapeutics plc was delisted on Jun 23, 2026; its insiders filed their last Form 4 on Nov 20, 2025; 18 institutions reported holding it in 13F filings for Q1 2026, worth $41.3K in total; no superinvestor held it.
Q1 2025 vs. Q4 2024
How the institutions holding Iterum Therapeutics plc changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Q1 2025 | Change |
|---|---|---|---|
| Holders | 24 | 20 | −4 |
| Shares | 1.23M | 1.12M | −113.5K (−9.2%) |
| Value | $2.18M | $1.38M | −$800.1K (−36.8%) |
New holders (2)
Institutions that held Iterum Therapeutics plc at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Resources Investment Advisors, LLC. | 101,000 | $124.2K | 0.00% |
| Two Sigma Securities, LLC | 10,709 | $13.2K | 0.00% |
Sold out (6)
Institutions that held Iterum Therapeutics plc at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Citadel Advisors LLC | 21,207 | $37.5K |
| Jane Street Group, LLC | 10,262 | $18.2K |
| Tower Research Capital LLC (TRC) | 710 | $1.26K |
| Barclays PLC | 500 | $885 |
| Cypress Capital Management LLC (WY) | 66 | $117 |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 13 | $23 |